PROMISE Study Examines Trikafta Use Among CF Patients
The Cystic Fibrosis Foundation's long-term observational study, PROMISE, is focused on Vertex' triple-combo therapy Trikafta.
0 Comments
PROMISE Study Examines Trikafta Use Among CF Patients
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed